Caris Life Sciences (CAI) Institutional Ownership
13F filers reported holding 54.1% of Caris Life Sciences (CAI) shares as of Jun 30, 2026, across 249 filers.
4 figures withheld by our checks. Each blank figure names its reason.
- Held by 13F filers
- 54.1%
- Jun 30, 2026
- 13F filers
- 249
- quarter ended Jun 30, 2026
- 13F value
- $2.8B
- 155.2M shares
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Denton John Russel | See Remarks | Disposed · Open-market sale | 7,500 | $31.82 | ↗ |
| Sep 17, 2026 | Brille Brian J | See Remarks | Acquired · Option exercise | 400,000 | $2.44 | ↗ |
| Sep 17, 2026 | Brille Brian J | See Remarks | Disposed · Open-market sale | 400,000 | $30.33 | ↗ |
| Sep 17, 2026 | Brille Brian J | See Remarks | Disposed · Option exercise | 400,000Stock Option | — | ↗ |
| Sep 4, 2026 | Spetzler David Baxley | President | Acquired · Option exercise | 250,000 | $2.44 | ↗ |
| Sep 4, 2026 | Spetzler David Baxley | President | Disposed · Open-market sale | 119,212 | $24.76 | ↗ |
| Sep 4, 2026 | Spetzler David Baxley | President | Disposed · Option exercise | 250,000Stock Option | — | ↗ |
| Sep 3, 2026 | Spetzler David Baxley | President | Acquired · Option exercise | 1,000,000 | $2.44 | ↗ |
| Sep 3, 2026 | Spetzler David Baxley | President | Disposed · Open-market sale | 393,100 | $24.76 | ↗ |
| Sep 3, 2026 | Spetzler David Baxley | President | Disposed · Open-market sale | 84,900 | $25.32 | ↗ |
| Sep 3, 2026 | Spetzler David Baxley | President | Disposed · Option exercise | 1,000,000Stock Option | — | ↗ |
| Aug 14, 2026 | Fredrickson David Paul | director | Acquired · Grant / award | 13,192 | — | ↗ |
| Aug 14, 2026 | Minor Lloyd | director | Acquired · Grant / award | 13,192 | — | ↗ |
| Aug 14, 2026 | Vacirca Jeff L | director | Acquired · Grant / award | 13,192 | — | ↗ |
| Aug 14, 2026 | Gilliam Joseph E | director | Acquired · Grant / award | 13,192 | — | ↗ |
| Aug 14, 2026 | PHILLIPS T DANNY | director | Acquired · Grant / award | 13,192 | — | ↗ |
| Aug 14, 2026 | CASTLEMAN PETER M | director | Acquired · Grant / award | 13,192 | — | ↗ |
| Aug 14, 2026 | JOHANSEN LAURA I | director | Acquired · Grant / award | 13,192 | — | ↗ |
| Aug 14, 2026 | HALBERT JON | director | Acquired · Grant / award | 13,192 | — | ↗ |
| May 29, 2026 | Knowles Jonathan Kenneth Charles | director | Acquired · Grant / award | 1,600 | $15.62 | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Caris Life Sciences do institutions hold?
13F filers reported holding 54.1% of Caris Life Sciences' shares as of Jun 30, 2026, across 249 filers.
How many 13F filers hold Caris Life Sciences?
Caris Life Sciences was held by 249 13F filers as of Jun 30, 2026.
Not investment advice.

